These findings reveal that the protective effects of CREBH activation may be leveraged to mitigate diet-induced obesity and associated metabolic abnormalities in both Fgf21-dependent and Fgf21-independent pathways. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.